0000899243-18-014568.txt : 20180531
0000899243-18-014568.hdr.sgml : 20180531
20180531172231
ACCESSION NUMBER: 0000899243-18-014568
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180529
FILED AS OF DATE: 20180531
DATE AS OF CHANGE: 20180531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Estrem Paul
CENTRAL INDEX KEY: 0001722374
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35405
FILM NUMBER: 18872671
MAIL ADDRESS:
STREET 1: 300 TRI-STATE INTERNATIONAL, SUITE 272
CITY: LINCOLNSHIRE
STATE: IL
ZIP: 60069
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MELINTA THERAPEUTICS, INC. /NEW/
CENTRAL INDEX KEY: 0001461993
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454440364
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 GEORGE STREET
STREET 2: SUITE 301
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
BUSINESS PHONE: 312 767 0291
MAIL ADDRESS:
STREET 1: 300 GEORGE STREET
STREET 2: SUITE 301
CITY: NEW HAVEN
STATE: CT
ZIP: 06511
FORMER COMPANY:
FORMER CONFORMED NAME: CEMPRA, INC.
DATE OF NAME CHANGE: 20120203
FORMER COMPANY:
FORMER CONFORMED NAME: Cempra Holdings, LLC
DATE OF NAME CHANGE: 20090414
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-29
0
0001461993
MELINTA THERAPEUTICS, INC. /NEW/
MLNT
0001722374
Estrem Paul
C/O MELINTA THERAPEUTICS, INC.
300 GEORGE STREET, SUITE 301
NEW HAVEN
CT
06511
0
1
0
0
Chief Financial Officer
Common Stock
2018-05-29
4
P
0
10000
5.00
A
10000
D
These shares were purchased from the underwriters pursuant to an underwritten public offering by the Issuer. The offering closed on May 29, 2018.
/s/ Paul Estrem
2018-05-31